SB-118 – An Act to Amend Title 24 of the Delaware Code Relating to Pharmacists

Sponsor[s]: Poore, Hall-Long

Co-sponsor[s]: Ennis, Henry

Synopsis: Allows pharmacists to substitute FDA-approved interchangeable biosimilar products for biological products with safeguards and provides some liability protections. To make a substitution, pharmacists must provide notice, make and maintain a label information/distribution record. Records would be maintained for three years.

Status: Senate Ready List (as of 9/17/2013)